دورية أكاديمية
Immune checkpoint inhibitors enhanced the antitumor efficacy of disitamab vedotin for patients with HER2-positive or HER2-low advanced or metastatic gastric cancer: a multicenter real-world study
| العنوان: | Immune checkpoint inhibitors enhanced the antitumor efficacy of disitamab vedotin for patients with HER2-positive or HER2-low advanced or metastatic gastric cancer: a multicenter real-world study |
|---|---|
| المؤلفون: | Nie, CaiyunAff1, Aff2, Aff3, Aff4, Xu, WeifengAff1, Aff2, Aff3, Aff4, Guo, Yanwei, Gao, Xiaohui, Lv, HuifangAff1, Aff2, Aff3, Aff4, Chen, BeibeiAff1, Aff2, Aff3, Aff4, Wang, JianzhengAff1, Aff2, Aff3, Aff4, Liu, Yingjun, Zhao, JingAff1, Aff2, Aff3, Aff4, Wang, SaiqiAff1, Aff2, Aff3, Aff4, He, YunduanAff1, Aff2, Aff3, Aff4, Chen, XiaobingAff1, Aff2, Aff3, Aff4, IDs1288502311735z_cor12 |
| المصدر: | BMC Cancer. 23(1) |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 14712407 |
|---|---|
| DOI: | 10.1186/s12885-023-11735-z |